Home›Signals›Clinical Trial Activity
■

Clinical Trial Activity

Active clinical trials by phase and status

50 Active Signals
IBRXImmunityBio, Inc.Biotech / Pharma
C
50/100
JAZZJazz Pharmaceuticals plcBiotech / Pharma
C
53/100
AGIOAgios PharmaceuticalsRare Disease
C
62/100
IDYAIDEAYA BiosciencesPrecision Oncology
C
57/100
RVMDRevolution MedicinesPrecision Oncology
C
53/100
AXSMAxsome TherapeuticsNeuroscience
D
38/100
IONSIonis PharmaceuticalsAntisense Therapeutics
C
63/100
AGENAgenus IncImmuno-Oncology
C
63/100
SRPTSarepta TherapeuticsGene Therapy
C
62/100
REGNRegeneron PharmaceuticalsAntibody Therapeutics
C
52/100
TOIThe Oncology Institute, Inc.Oncology
C
61/100
SMMTSummit Therapeutics Inc.Biotech / Pharma
D
48/100
ISRGIntuitive Surgical, Inc.Biotech / Pharma
F
15/100
UCBNVUCB SANeurology Immunology
C
63/100
ICLRICON plcCRO Clinical Research
C
52/100
DXCMDexCom IncDiabetes Tech
F
17/100
NTRANatera IncGenetics Diagnostics
C
52/100
SNDXSyndax PharmaceuticalsOncology
C
58/100
ARWRArrowhead PharmaceuticalsRNAi Therapeutics
C
53/100
MIRMMirum PharmaceuticalsLiver Disease
C
56/100
TVTXTravere TherapeuticsNephrology
C
60/100
ARGXargenx SEAutoimmune
C
52/100
NVONovo NordiskDiabetes/Obesity
C
51/100
BAYRYBayer AGPharma/Crop Science
C
56/100
SNYSanofi SAImmunology
C
52/100
AZNAstraZenecaOncology/Respiratory
C
52/100
MRKMerck & CoOncology/Vaccines
C
52/100
PFEPfizer IncDiversified Pharma
C
52/100
JNJJohnson & JohnsonDiversified Pharma
C
52/100
LLYEli Lilly and CompanyDiabetes/Oncology
C
52/100
BMYBristol-Myers SquibbOncology
C
51/100
BGNEBeiGene LtdOncology
C
63/100
TGTXTG TherapeuticsOncology
C
55/100
GRFSGrifols SAPlasma Therapeutics
C
53/100
ACADACADIA PharmaceuticalsNeuroscience
C
53/100
RCUSArcus BiosciencesImmuno-Oncology
C
60/100
ARQTArcus BiosciencesImmuno-Oncology
C
51/100
GILDGilead SciencesAntiviral
C
52/100
CLDXCelldex TherapeuticsImmuno-Oncology
C
56/100
ABBVAbbVie IncImmunology
C
52/100
CORTCorcept TherapeuticsEndocrinology
D
46/100
NBIXNeurocrine BiosciencesNeuroscience
C
52/100
BIIBBiogen IncNeuroscience
C
52/100
VRTXVertex PharmaceuticalsGene Therapy
C
52/100
SYNHSyneos HealthCRO Biopharmaceutical
SGENSeagen IncOncology ADC
BNTXBioNTech SEmRNA Therapeutics
C
53/100
MRNAModerna IncmRNA Therapeutics
C
60/100
EXELExelixis IncOncology
C
54/100
ITCIIntra-Cellular TherapiesNeuroscience
C
63/100
Not financial advice. BiotechSign data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.
© 2026 BiotechSign — AI-powered biotech catalyst intelligence